バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測

• 英文タイトル：Global Biosimilar Monoclonal Antibody Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03834 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、バイオシミラーモノクローナル抗体の世界市場について調査・分析し、バイオシミラーモノクローナル抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（合成化学、バイオ製薬、その他）、用途別（慢性および自己免疫疾患、腫瘍学、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のバイオシミラーモノクローナル抗体市場動向 ・主要企業別マーケットシェア ・バイオシミラーモノクローナル抗体の種類別市場規模2014-2019 （合成化学、バイオ製薬、その他） ・バイオシミラーモノクローナル抗体の用途別市場規模2014-2019 （慢性および自己免疫疾患、腫瘍学、その他） ・バイオシミラーモノクローナル抗体の北米市場：主要企業・種類別/用途別市場規模 ・バイオシミラーモノクローナル抗体のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・バイオシミラーモノクローナル抗体の中国市場：主要企業・種類別/用途別市場規模 ・バイオシミラーモノクローナル抗体の日本国内市場：主要企業・種類別/用途別市場規模 ・バイオシミラーモノクローナル抗体の東南アジア市場：主要企業・種類別/用途別市場規模 ・バイオシミラーモノクローナル抗体のインド市場：主要企業・種類別/用途別市場規模 ・バイオシミラーモノクローナル抗体の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Biocon、Accord Healthcare、AET Biotech、Amgen、Celltrion、Reddy's Laboratories、Hospira、3SBio、Allergan、Alvartis） ・バイオシミラーモノクローナル抗体の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthritis, Hodgkins lymphoma, chronic lymphocytic leukemia, and others.In 2018, the global Biosimilar Monoclonal Antibody market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biosimilar Monoclonal Antibody status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosimilar Monoclonal Antibody development in United States, Europe and China.

The key players covered in this study
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy’s Laboratories
Hospira
3SBio
Allergan
Alvartis

Market segment by Type, the product can be split into
Synthetic Chemicals
Biopharmaceuticals
Others

Market segment by Application, split into
Chronic & Autoimmune Diseases
Oncology
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biosimilar Monoclonal Antibody status, future forecast, growth opportunity, key market and key players.
To present the Biosimilar Monoclonal Antibody development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biosimilar Monoclonal Antibody are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type (2014-2025)
1.4.2 Synthetic Chemicals
1.4.3 Biopharmaceuticals
1.4.4 Others
1.5 Market by Application
1.5.1 Global Biosimilar Monoclonal Antibody Market Share by Application (2014-2025)
1.5.2 Chronic & Autoimmune Diseases
1.5.3 Oncology
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Biosimilar Monoclonal Antibody Market Size
2.2 Biosimilar Monoclonal Antibody Growth Trends by Regions
2.2.1 Biosimilar Monoclonal Antibody Market Size by Regions (2014-2025)
2.2.2 Biosimilar Monoclonal Antibody Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Biosimilar Monoclonal Antibody Market Size by Manufacturers
3.1.1 Global Biosimilar Monoclonal Antibody Revenue by Manufacturers (2014-2019)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilar Monoclonal Antibody Key Players Head office and Area Served
3.3 Key Players Biosimilar Monoclonal Antibody Product/Solution/Service
3.4 Date of Enter into Biosimilar Monoclonal Antibody Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Biosimilar Monoclonal Antibody Market Size by Type (2014-2019)
4.2 Global Biosimilar Monoclonal Antibody Market Size by Application (2014-2019)

5 United States
5.1 United States Biosimilar Monoclonal Antibody Market Size (2014-2019)
5.2 Biosimilar Monoclonal Antibody Key Players in United States
5.3 United States Biosimilar Monoclonal Antibody Market Size by Type
5.4 United States Biosimilar Monoclonal Antibody Market Size by Application

6 Europe
6.1 Europe Biosimilar Monoclonal Antibody Market Size (2014-2019)
6.2 Biosimilar Monoclonal Antibody Key Players in Europe
6.3 Europe Biosimilar Monoclonal Antibody Market Size by Type
6.4 Europe Biosimilar Monoclonal Antibody Market Size by Application

7 China
7.1 China Biosimilar Monoclonal Antibody Market Size (2014-2019)
7.2 Biosimilar Monoclonal Antibody Key Players in China
7.3 China Biosimilar Monoclonal Antibody Market Size by Type
7.4 China Biosimilar Monoclonal Antibody Market Size by Application

8 Japan
8.1 Japan Biosimilar Monoclonal Antibody Market Size (2014-2019)
8.2 Biosimilar Monoclonal Antibody Key Players in Japan
8.3 Japan Biosimilar Monoclonal Antibody Market Size by Type
8.4 Japan Biosimilar Monoclonal Antibody Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Biosimilar Monoclonal Antibody Market Size (2014-2019)
9.2 Biosimilar Monoclonal Antibody Key Players in Southeast Asia
9.3 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type
9.4 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application

10 India
10.1 India Biosimilar Monoclonal Antibody Market Size (2014-2019)
10.2 Biosimilar Monoclonal Antibody Key Players in India
10.3 India Biosimilar Monoclonal Antibody Market Size by Type
10.4 India Biosimilar Monoclonal Antibody Market Size by Application

11 Central & South America
11.1 Central & South America Biosimilar Monoclonal Antibody Market Size (2014-2019)
11.2 Biosimilar Monoclonal Antibody Key Players in Central & South America
11.3 Central & South America Biosimilar Monoclonal Antibody Market Size by Type
11.4 Central & South America Biosimilar Monoclonal Antibody Market Size by Application

12 International Players Profiles
12.1 Biocon
12.1.1 Biocon Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biosimilar Monoclonal Antibody Introduction
12.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.1.5 Biocon Recent Development
12.2 Accord Healthcare
12.2.1 Accord Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biosimilar Monoclonal Antibody Introduction
12.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.2.5 Accord Healthcare Recent Development
12.3 AET Biotech
12.3.1 AET Biotech Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biosimilar Monoclonal Antibody Introduction
12.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.3.5 AET Biotech Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biosimilar Monoclonal Antibody Introduction
12.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 Celltrion
12.5.1 Celltrion Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biosimilar Monoclonal Antibody Introduction
12.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.5.5 Celltrion Recent Development
12.6 Reddy’s Laboratories
12.6.1 Reddy’s Laboratories Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biosimilar Monoclonal Antibody Introduction
12.6.4 Reddy’s Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.6.5 Reddy’s Laboratories Recent Development
12.7 Hospira
12.7.1 Hospira Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biosimilar Monoclonal Antibody Introduction
12.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.7.5 Hospira Recent Development
12.8 3SBio
12.8.1 3SBio Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biosimilar Monoclonal Antibody Introduction
12.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.8.5 3SBio Recent Development
12.9 Allergan
12.9.1 Allergan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biosimilar Monoclonal Antibody Introduction
12.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.9.5 Allergan Recent Development
12.10 Alvartis
12.10.1 Alvartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biosimilar Monoclonal Antibody Introduction
12.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)
12.10.5 Alvartis Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Biosimilar Monoclonal Antibody Key Market Segments
Table Key Players Biosimilar Monoclonal Antibody Covered
Table Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Biosimilar Monoclonal Antibody Market Size Market Share by Type 2014-2025
Figure Synthetic Chemicals Figures
Table Key Players of Synthetic Chemicals
Figure Biopharmaceuticals Figures
Table Key Players of Biopharmaceuticals
Figure Others Figures
Table Key Players of Others
Table Global Biosimilar Monoclonal Antibody Market Size Growth by Application 2014-2025 (Million US$)
Figure Chronic & Autoimmune Diseases Case Studies
Figure Oncology Case Studies
Figure Others Case Studies
Figure Biosimilar Monoclonal Antibody Report Years Considered
Table Global Biosimilar Monoclonal Antibody Market Size 2014-2025 (Million US$)
Figure Global Biosimilar Monoclonal Antibody Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Size by Regions 2014-2025 (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Size by Regions 2014-2019 (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Share by Regions 2014-2019
Figure Global Biosimilar Monoclonal Antibody Market Share by Regions 2014-2019
Figure Global Biosimilar Monoclonal Antibody Market Share by Regions 2019
Table Market Top Trends
Table Global Biosimilar Monoclonal Antibody Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Share by Manufacturers (2014-2019)
Figure Global Biosimilar Monoclonal Antibody Market Share by Manufacturers in 2018
Table Global Biosimilar Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Biosimilar Monoclonal Antibody Product/Solution/Service
Table Date of Enter into Biosimilar Monoclonal Antibody Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar Monoclonal Antibody Market Size by Type (2014-2019) (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Size Share by Type (2014-2019)
Figure Global Biosimilar Monoclonal Antibody Market Size Market Share by Type (2014-2019)
Table Global Biosimilar Monoclonal Antibody Market Size by Application (2014-2019) (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Size Share by Application (2014-2019)
Figure Global Biosimilar Monoclonal Antibody Market Size Market Share by Application (2014-2019)
Figure Global Biosimilar Monoclonal Antibody Revenue Market Share by Application in 2018
Figure United States Biosimilar Monoclonal Antibody Market Size 2014-2019 (Million US$)
Table United States Key Players Biosimilar Monoclonal Antibody Revenue (2018-2019) (Million US$)
Table United States Key Players Biosimilar Monoclonal Antibody Market Share (2018-2019)
Table United States Biosimilar Monoclonal Antibody Market Size by Type (2014-2019) (Million US$)
Table United States Biosimilar Monoclonal Antibody Market Share by Type (2014-2019)
Table United States Biosimilar Monoclonal Antibody Market Size by Application (2014-2019) (Million US$)
Table United States Biosimilar Monoclonal Antibody Market Share by Application (2014-2019)
Figure Europe Biosimilar Monoclonal Antibody Market Size 2014-2019 (Million US$)
Table Europe Key Players Biosimilar Monoclonal Antibody Revenue (2018-2019) (Million US$)
Table Europe Key Players Biosimilar Monoclonal Antibody Market Share (2018-2019)
Table Europe Biosimilar Monoclonal Antibody Market Size by Type (2014-2019) (Million US$)
Table Europe Biosimilar Monoclonal Antibody Market Share by Type (2014-2019)
Table Europe Biosimilar Monoclonal Antibody Market Size by Application (2014-2019) (Million US$)
Table Europe Biosimilar Monoclonal Antibody Market Share by Application (2014-2019)
Figure China Biosimilar Monoclonal Antibody Market Size 2014-2019 (Million US$)
Table China Key Players Biosimilar Monoclonal Antibody Revenue (2018-2019) (Million US$)
Table China Key Players Biosimilar Monoclonal Antibody Market Share (2018-2019)
Table China Biosimilar Monoclonal Antibody Market Size by Type (2014-20189) (Million US$)
Table China Biosimilar Monoclonal Antibody Market Share by Type (2014-2019)
Table China Biosimilar Monoclonal Antibody Market Size by Application (2014-2019) (Million US$)
Table China Biosimilar Monoclonal Antibody Market Share by Application (2014-2019)
Figure Japan Biosimilar Monoclonal Antibody Market Size 2014-2019 (Million US$)
Table Japan Key Players Biosimilar Monoclonal Antibody Revenue (2018-2019) (Million US$)
Table Japan Key Players Biosimilar Monoclonal Antibody Market Share (2018-2019)
Table Japan Biosimilar Monoclonal Antibody Market Size by Type (2014-2019) (Million US$)
Table Japan Biosimilar Monoclonal Antibody Market Share by Type (2014-2019)
Table Japan Biosimilar Monoclonal Antibody Market Size by Application (2014-2019) (Million US$)
Table Japan Biosimilar Monoclonal Antibody Market Share by Application (2014-2019)
Figure Southeast Asia Biosimilar Monoclonal Antibody Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Biosimilar Monoclonal Antibody Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Biosimilar Monoclonal Antibody Market Share (2018-2019)
Table Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Biosimilar Monoclonal Antibody Market Share by Type (2014-2019)
Table Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Biosimilar Monoclonal Antibody Market Share by Application (2014-2019)
Figure India Biosimilar Monoclonal Antibody Market Size 2014-2019 (Million US$)
Table India Key Players Biosimilar Monoclonal Antibody Revenue (2018-2019) (Million US$)
Table India Key Players Biosimilar Monoclonal Antibody Market Share (2018-2019)
Table India Biosimilar Monoclonal Antibody Market Size by Type (2014-2019) (Million US$)
Table India Biosimilar Monoclonal Antibody Market Share by Type (2014-2019)
Table India Biosimilar Monoclonal Antibody Market Size by Application (2014-2019) (Million US$)
Table India Biosimilar Monoclonal Antibody Market Share by Application (2014-2019)
Figure Central & South America Biosimilar Monoclonal Antibody Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Biosimilar Monoclonal Antibody Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Biosimilar Monoclonal Antibody Market Share (2018-2019)
Table Central & South America Biosimilar Monoclonal Antibody Market Size by Type (2014-2019) (Million US$)
Table Central & South America Biosimilar Monoclonal Antibody Market Share by Type (2014-2019)
Table Central & South America Biosimilar Monoclonal Antibody Market Size by Application (2014-2019) (Million US$)
Table Central & South America Biosimilar Monoclonal Antibody Market Share by Application (2014-2019)
Table Biocon Company Details
Table Biocon Revenue in Biosimilar Monoclonal Antibody Business (2014-2019) (Million US$)
Figure Biocon Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table Biocon Recent Development
Table Accord Healthcare Company Details
Table Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure Accord Healthcare Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table Accord Healthcare Recent Development
Table AET Biotech Company Details
Table AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure AET Biotech Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table AET Biotech Recent Development
Table Amgen Company Details
Table Amgen Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table Amgen Recent Development
Table Celltrion Company Details
Table Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure Celltrion Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table Celltrion Recent Development
Table Reddy's Laboratories Company Details
Table Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure Reddy's Laboratories Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table Reddy's Laboratories Recent Development
Table Hospira Company Details
Table Hospira Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure Hospira Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table Hospira Recent Development
Table 3SBio Company Details
Table 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure 3SBio Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table 3SBio Recent Development
Table Allergan Company Details
Table Allergan Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table Allergan Recent Development
Table Alvartis Company Details
Table Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2014-2019)(Million US$)
Figure Alvartis Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2014-2019)
Table Alvartis Recent Development
Table Global Biosimilar Monoclonal Antibody Market Size by Regions (Million US$) 2019-2025
Figure Global Biosimilar Monoclonal Antibody Market Size Share by Regions (2019-2025)
Figure Global Biosimilar Monoclonal Antibody Market Size Share by Regions in 2025
Figure United States Biosimilar Monoclonal Antibody Market Size Forecast (2019-2025)(Million USD)
Figure Europe Biosimilar Monoclonal Antibody Market Size Forecast (2019-2025)(Million USD)
Figure China Biosimilar Monoclonal Antibody Market Size Forecast (2019-2025)(Million USD)
Figure Japan Biosimilar Monoclonal Antibody Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Biosimilar Monoclonal Antibody Market Size Forecast (2019-2025)(Million USD)
Figure India Biosimilar Monoclonal Antibody Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Biosimilar Monoclonal Antibody Market Size Forecast (2019-2025)(Million USD)
Table Global Biosimilar Monoclonal Antibody Market Size by Product (2019-2025) (Million US$)
Figure Global Biosimilar Monoclonal Antibody Market Size by Product (2019-2025)
Figure Global Biosimilar Monoclonal Antibody Market Size by Product in 2025
Table Global Biosimilar Monoclonal Antibody Market Size by Application (2019-2025) (Million US$)
Figure Global Biosimilar Monoclonal Antibody Market Size by Application (2019-2025)
Figure Global Biosimilar Monoclonal Antibody Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---